Background Studies that have evaluated the use of intravenous vitamin C in adults with
sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown …

Purpose We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients
with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international, …

Background We describe demographic features, treatments and clinical outcomes in the
International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) COVID-19 …

Objectives To compare severity and clinical outcomes from Omicron as compared with the
Delta variant and to compare outcomes between Omicron sublineages. Methods We …

Background Improvements in health-related outcomes for critically ill adults in low and lower-middle
income countries need systematic investments in research capacity and …

Purpose We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given
daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe …

To make clinical and biological observations within a time frame that is likely to benefit
patients during disease out breaks, coordination of global research must match the speed of …

Background Sepsis is a global health problem. Limited data exist on the prevalence of sepsis
using current definitions in ICUs in India. Research Question In adult patients admitted to …

Coronavirus disease 2019 cases in India continue to increase and are expected to peak
over the next few weeks. Based on some projection models, India is expected to have more …

Background and Purpose— We sought to evaluate the available literature to determine
whether primary seizure prevention with antiepileptic drugs reduces the risk of poor outcomes …